These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 37218723)

  • 1. Commercial hybrid closed-loop systems available for a patient with type 1 diabetes in 2022.
    Seget S; Tekielak A; Rusak E; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2023; 29(1):30-36. PubMed ID: 37218723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid closed-loop therapy: Where are we in 2021?
    Leelarathna L; Choudhary P; Wilmot EG; Lumb A; Street T; Kar P; Ng SM
    Diabetes Obes Metab; 2021 Mar; 23(3):655-660. PubMed ID: 33269551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review.
    Mameli C; Smylie GM; Galati A; Rapone B; Cardona-Hernandez R; Zuccotti G; Delvecchio M
    Eur J Pediatr; 2023 May; 182(5):1949-1963. PubMed ID: 36809498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes.
    Ng SM; Wright NP; Yardley D; Campbell F; Randell T; Trevelyan N; Ghatak A; Hindmarsh PC
    BMC Med; 2024 Apr; 22(1):175. PubMed ID: 38659016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility Study of a Hybrid Closed-Loop System with Automated Insulin Correction Boluses.
    Nimri R; Grosman B; Roy A; Nir J; Fisch Shvalb N; Kurtz N; Loewenthal N; Gillon-Keren M; Muller I; Atlas E; Phillip M
    Diabetes Technol Ther; 2021 Apr; 23(4):268-276. PubMed ID: 33185480
    [No Abstract]   [Full Text] [Related]  

  • 6. Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control.
    Lepore G; Rossini A; Bellante R; Corsi A; Scaranna C; Dodesini AR; Trevisan R
    Acta Diabetol; 2022 Oct; 59(10):1309-1315. PubMed ID: 35857108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Temporary Glycemic Target Use in the Hybrid and Advanced Hybrid Closed-Loop Systems.
    Dovc K; Battelino T; Beck RW; Sibayan J; Bailey RJ; Calhoun P; Turcotte C; Weinzimer S; Smigoc Schweiger D; Nimri R; Bergenstal RM
    Diabetes Technol Ther; 2022 Nov; 24(11):848-852. PubMed ID: 35848991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670G.
    Weinzimer SA; Bailey RJ; Bergenstal RM; Nimri R; Beck RW; Schatz D; Ambler-Osborn L; Schweiger DS; von dem Berge T; Sibayan J; Johnson ML; Calhoun P; Phillip M;
    Diabetes Technol Ther; 2022 Aug; 24(8):573-582. PubMed ID: 35363054
    [No Abstract]   [Full Text] [Related]  

  • 9. A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.
    Jendle J; Buompensiere MI; Ozdemir Saltik AZ; de Portu S; Smith-Palmer J; Pollock RF; Cohen O
    Diabetes Technol Ther; 2023 Dec; 25(12):864-876. PubMed ID: 37801658
    [No Abstract]   [Full Text] [Related]  

  • 10. Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus-a National Health Service pilot initiative in England.
    Ng SM; Wright NP; Yardley D; Campbell F; Randell T; Trevelyan N; Ghatak A; Hindmarsh PC
    Diabet Med; 2023 Feb; 40(2):e15015. PubMed ID: 36424877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes with MiniMed
    Abraham MB; Smith GJ; Dart J; Davis EA; Jones TW
    Diabetes Technol Ther; 2024 May; 26(5):341-345. PubMed ID: 38215208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor.
    Cordero TL; Dai Z; Arrieta A; Niu F; Vella M; Shin J; Rhinehart AS; McVean J; Lee SW; Slover RH; Forlenza GP; Shulman DI; Pop-Busui R; Thrasher JR; Kipnes MS; Christiansen MP; Buckingham BA; Pihoker C; Sherr JL; Kaiserman KB; Vigersky RA
    Diabetes Technol Ther; 2023 Sep; 25(9):652-658. PubMed ID: 37252734
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed‑loop system: A randomized controlled trial.
    Elbarbary NS; Ismail EAR
    Diabetes Res Clin Pract; 2022 Sep; 191():110045. PubMed ID: 35987309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Peek Under the Hood: Explaining the MiniMed™ 780G Algorithm with Meal Detection Technology.
    Grosman B; Roy A; Lintereur L; Turksoy K; Benedetti A; Cordero TL; Vigersky RA; McVean J; Rhinehart AS; Cohen O
    Diabetes Technol Ther; 2024 Mar; 26(S3):17-23. PubMed ID: 38377324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.
    Carlson AL; Sherr JL; Shulman DI; Garg SK; Pop-Busui R; Bode BW; Lilenquist DR; Brazg RL; Kaiserman KB; Kipnes MS; Thrasher JR; Reed JHC; Slover RH; Philis-Tsimikas A; Christiansen M; Grosman B; Roy A; Vella M; Jonkers RAM; Chen X; Shin J; Cordero TL; Lee SW; Rhinehart AS; Vigersky RA
    Diabetes Technol Ther; 2022 Mar; 24(3):178-189. PubMed ID: 34694909
    [No Abstract]   [Full Text] [Related]  

  • 16. Reducing Diabetes Burden in Medtronic's Automated Insulin Delivery Systems.
    Forlenza GP; Dai Z; Niu F; Shin JJ
    Diabetes Technol Ther; 2024 Mar; 26(S3):7-16. PubMed ID: 38377321
    [No Abstract]   [Full Text] [Related]  

  • 17. Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users.
    Silva JD; Lepore G; Battelino T; Arrieta A; Castañeda J; Grossman B; Shin J; Cohen O
    Diabetes Technol Ther; 2022 Feb; 24(2):113-119. PubMed ID: 34524003
    [No Abstract]   [Full Text] [Related]  

  • 18. Can the AHCL System Be Used in T1D Patients with Borderline TDDI? A Case Report.
    Tekielak A; Seget S; Rusak E; Jarosz-Chobot P
    Sensors (Basel); 2021 Oct; 21(21):. PubMed ID: 34770502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Satisfaction While Maintaining Safety and High Time in Range (TIR) With a Medtronic Investigational Enhanced Advanced Hybrid Closed-Loop (e-AHCL) System.
    Yuan CY; Kong YW; Amoore T; Brown K; Grosman B; Jenkins A; Jones H; Kurtz N; Lee MH; MacIsaac R; Netzer E; Paldus B; Robinson L; Roy A; Sims CM; Trawley S; Vogrin S; O'Neal DN
    Diabetes Care; 2024 Apr; 47(4):747-755. PubMed ID: 38381515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two advanced hybrid closed loop in a pediatric population with type 1 diabetes: a real-life observational study.
    Schiaffini R; Deodati A; Nicoletti MC; Carducci C; Ciampalini P; Lorubbio A; Matteoli MC; Pampanini V; Patera IP; Rapini N; Cianfarani S
    Acta Diabetol; 2022 Jul; 59(7):959-964. PubMed ID: 35451679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.